Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRA-ARTERIALGeneric

ABLYSINOL

DEHYDRATED ALCOHOL

Standard Dose
99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ABLYSINOL is listed in Drugs@FDA under application 207987 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DEHYDRATED ALCOHOL Form and strength SOLUTION;INTRA-ARTERIAL - 99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BPI LABS Submission history Latest submission status date: 2018-06-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview ABLYSINOL is listed in Drugs@FDA under application 207987 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DEHYDRATED ALCOHOL Form and strength SOLUTION;INTRA-ARTERIAL - 99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BPI LABS Submission history Latest submission status date: 2018-06-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.